Hope Clinical Trials

Miami, Florida 33165

0 studies enrolling now · 4 studies all time

What they study most

COVID 19 Disease, Lupus Erythematosus, Lupus Nephritis, Mild-to-Moderate COVID-19, Systemic Lupus Erythematosus

Studies at this site

• Study of EQ001 (Itolizumab) in Systemic Lupus Erythematosus With or Without Active Proliferative Nephritis — Completed
• Tafenoquine in Patients With Mild to Moderate COVID-19 — Completed
• A Clinical Study to Assess the Physiologic Effects of KB109 in Patients With COVID-19 on Gut Microbiota Structure and Function — Completed
• A Phase II Study of M2951 in SLE — Stopped early